Disease Risk Evaluation-related Imaging Biomarker Detection Service

Imaging biomarkers have an important position in the field of medical diagnosis, and they also have their advantages and potential in the field of disease risk evaluation. As an expert in the field of biomarkers, in addition to providing single biomarker testing services and multiple biomarker testing services, Creative BioMart Biomarker also provides scientific research outsourcing services for imaging biomarker research to help customers advance research projects on imaging biomarkers in the field of disease risk assessment. We have an advanced imaging technology platform and a professional technical team, and strive to provide customers with high-quality and professional technical services to help customers shorten the research cycle and reduce research costs.


Disease risk evaluation is a means of clinical importance, it can stratify patients according to risk factors, which helps to choose appropriate treatment measures for patients at different levels and carry out appropriate routine care. Disease risk evaluation is helpful to reduce the incidence and mortality of severe diseases. For example, early risk assessment of patients with atherosclerotic disease can effectively reduce the incidence and mortality of myocardial infarction associated with it. Imaging biomarkers are a class of indicators that can be used for disease risk evaluation. In the early diagnosis and risk assessment of diseases, the development of medical imaging technology allows doctors to more easily, quickly and intuitively detect the condition of organs or tissues, select specific imaging biomarkers as research objects, and use the test results as a basis to assess the possibility of a patient developing a certain disease. The rational use of imaging biomarkers can advance the research progress of disease risk evaluation, thereby promoting the research progress of disease treatment, monitoring and nursing. In addition, imaging biomarkers can be detected in a non-invasive manner, which is conducive to promoting their widespread clinical application. In view of the important position of imaging biomarkers in disease risk evaluation, it is necessary to use medical imaging technology to conduct research on imaging biomarkers in disease risk evaluation in order to screen out biomarkers that may have an important position in disease risk evaluation. For example, intracranial atherosclerotic disease (ICAD) is one of the causes of stroke. Quantifying the severity of intracranial stenosis in these patients can assess the risk of recurrent ipsilateral stroke and assist in the risk stratification of patients.

Disease Risk Evaluation-related Imaging Biomarker Detection Service


Disease risk evaluation-related imaging biomarker detection service is suitable for the research of various diseases, including stroke, myocardial infarction, etc.

Our Advantages

  • Multiple imaging biomarkers detection technology platforms
  • Ensure high accuracy and precision imaging biomarkers detection service
  • Provide quantitative imaging biomarkers detection service
  • Provide detailed professional analysis report
  • Customized service scheme according to the specific needs
  • Shorter service cycle and prices that are more competitive
  • Experienced technical team

Workflow of Imaging Biomarker Detection at Creative BioMart Biomarker

Disease Risk Evaluation-related Imaging Biomarker Detection Service

At Creative BioMart Biomarker, we provide customers with high-quality imaging biomarker detection services related to disease risk evaluation. Customers can discuss with our expert team based on specific research needs or research objects, and we will work out the appropriate experimental plan as soon as possible. Our technical team has extensive experience in the field of imaging biomarkers, and has been strictly controlling every process in the imaging biomarker detection service to ensure that customers are provided with accurate test results. If you are seeking related services, Creative BioMart Biomarker may be your ideal choice, please feel free to contact us for more information.


  1. Banerjee, C.; Chimowitz, M. I. Stroke caused by atherosclerosis of the major intracranial arteries. Circulation Research. 2017, 120(3): 502-513.
  2. Lin, J. S.; et al. Nontraditional risk factors in cardiovascular disease risk assessment. JAMA. 2018, 320(3): 281-297.


Contact Us


Enter your email here to subscribe